EMILY MYERS: Open Payments
NPI 1801318639 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$493 in 15 payments from 11 companies in 2025. Trend: 2023 $433 · 2024 $637 · 2025 $493
Food & beverage: $473Education: $20
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 2 | $148 |
| Janssen Biotech, Inc. | 2 | $61 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Pharmacosmos Therapeutics Inc. | 1 | $43 |
| Caris MPI, Inc. | 1 | $34 |
| Ferring Pharmaceuticals Inc. | 2 | $34 |
| Dendreon Pharmaceuticals LLC | 1 | $34 |
| Exelixis Inc. | 1 | $29 |
| Astellas Pharma Global Development | 1 | $23 |
| Fennec Pharmaceuticals, Inc. | 1 | $22 |
Products named: PADCEV, RYBREVANT, PLUVICTO, MONOFERRIC, MI CANCER SEEK, ADSTILADRIN, PROVENGE, CABOMETYX.
Industry payments across IN — which companies pay providers there.
